
Melanoma patients in England get fast-track access to cancer vaccine
Patients with an advanced type of skin melanoma in England will be given fast-track access to a “revolutionary” new cancer vaccine as part of an NHS trial. The vaccine, known as iSCIB1+ (ImmunoBody), helps the immune system recognise cancer cells and …